“GLP-compliant general oral (gavage) toxicity studies of omaveloxolone were conducted in Sprague Dawley rat and cynomolgus monkey, with durations up to 26 and 39 weeks, respectively.”
✓ VerifiedFDA pharmacology/toxicology review, p. 37Source ↗
Why that species
Monkey chosen as non-rodent because dogs develop species-specific GI toxicity with the related compound bardoxolone methyl
“Monkeys were chosen as the non-rodent non-clinical species in the omaveloxolone testing programme as dogs have previously been shown to develop species-specific gastrointestinal toxicity following repeated dosing with the chemically related substance, bardoxolone methyl.”
“Male and female cynomolgus monkeys (9-10/sex/group) were administered doses of 0 (sesame oil), 10, 30, or 100 mg/kg RTA 408 by daily oral gavage for 39 weeks with 4 weeks recovery;”
✓ VerifiedFDA pharmacology/toxicology review, p. 16Source ↗